Search database
LIST OPTIONS
Filter
24
Filtered Results: 24
Text search: European Environment Agency EAA
Featured
Language
Document type
Studies & Reports
10
No document type
7
Guidelines
3
Strategic & Response Plan
2
Resource Platforms
1
Fact sheets
1
Countries / Regions
Western and Central Europe
2
Nigeria
1
Global
1
Africa
1
Middle East and North Africa
1
Denmark
1
Zambia
1
Authors & Publishers
World Health Organization WHO
3
et al.
2
European Union EU
2
Food and Agriculture Organization of the United Nations FAO
2
World Health Organisation (WHO)
2
BUKO Pharma-Kampagne
1
Convention on Biological Diversity
1
DHS Program
1
European Commission EC
1
European Environment Agency EAA
1
Gabrys, J.
1
Greenpeace Germany
1
High-Level Panel on Humanitarian Financing Report to the Secretary-General
1
Jachia, Lorenza
1
KIT (Royal Tropical Institute) Development Policy & Practice/ Vrije Universiteit Amsterdam
1
Meyfroidt, P.
1
Ministry of Health, Zambia
1
Pim Cuijpers, Laura Shields-Zeeman, Bethany Hipple Walters, Ionela Petrea
1
Romanello M., van Daalen K., et al.
1
The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu
1
United Nations Children's Fund (UNICEF)
1
United Nations Economic Commission for Europe
1
United Nations Office on Drugs and Crime
1
University of Zambia
1
World Humanitarian Summit
1
Xiaoxu Wu, Yongmei Lu, Sen Zhou et al.
1
Publication Years
Category
Key Resources
3
Countries
2
Toolboxes
Planetary Health
10
AMR
5
Mental Health
3
Disability
1
Cholera
1
Pharmacy
1
NTDs
1
Global Health Education
1
Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity and draws conclusions relevant to the further implementation of the Convention. GBO-5 pro... more

Analysis of drug markets - Opiates, cocaine, cannabis, synthetic drugs

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -3-
PNAS 2022 Vol. 119 No. 7 e2109217118
This document focuses on the management of patients affected by gambiense HAT and constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa... more